Pharma major Lupin announced the completion of the United States Food and Drug Administration (U.S. FDA) inspection at its Goa manufacturing facility. The inspection was carried out between January 28 to February 8, 2019.
The inspection at the Goa facility closed with 2 observations. The observations are procedural in nature and the Company is confident of addressing them satisfactorily.
Shares of LUPIN LTD. was last trading in BSE at Rs.830.4 as compared to the previous close of Rs. 821.75. The total number of shares traded during the day was 181553 in over 3222 trades.
The stock hit an intraday high of Rs. 835.5 and intraday low of 805.85. The net turnover during the day was Rs. 149594883.